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ABSTRACT 
Genome-scale flux balance models of metabolism provide testable predictions of 
all metabolic rates in an organism, by assuming that the cell is optimizing a metabolic 
goal known as the objective function. In the first chapter of this dissertation, we introduce 
an efficient inverse flux balance analysis (invFBA) approach, based on linear 
programming duality, to characterize the space of possible objective functions compatible 
with measured fluxes. After testing our algorithm on simulated E. coli data and time-
dependent S. oneidensis fluxes inferred from gene expression, we apply our inverse 
approach to flux measurements in long-term evolved E. coli strains, revealing objective 
functions that provide insight into metabolic adaptation trajectories. 
For over a hundred years, enzymes, or the proteins that catalyze metabolic 
reactions, have been characterized in vitro, even though the aqueous solution of a test 
tube little resembles the crowded intracellular milieu. Since few metabolites show unique 
fluorescent signatures, metabolism is all but invisible, greatly complicating efforts to 
describe fluxes in vivo. In the second chapter of this dissertation, we introduce a new 
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technique called EIFFL (Estimation of Intracellular Flux through Fluorescence Loss) for 
visualizing the flux through a reaction inside single E. coli cells, using a substrate that 
undergoes an enzyme-catalyzed loss of fluorescence. EIFFL would not only further our 
quantitative understanding of metabolism, but enable us to promptly detect enzymes that 
confer clinically meaningful states, such as antibiotic resistance. We present a particular 
instance of EIFFL that couples nfsA, the major nitroreductase of E. coli responsible for 
its antibiotic sensitivity to nitrofurantoin, to 2-NBDG, a glucose derivative that loses 
fluorescence upon being reduced by nfsA with NADPH. We correlate the flux through 
the reaction with the concentration of a fluorescently tagged nfsA and measure the “flux 
noise” across a population of E. coli cells. Given that nfsA abolishes 2-NBDG 
fluorescence by the same molecular mechanism that it activates nitrofurantoin, EIFFL 
could serve as a means to rapidly infer the antibiotic resistance of single pathogenic E. 
coli cells directly from clinical samples. 
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CHAPTER 1:  
INTRODUCTION 
 
Metabolic networks, which convert nutrients supplied by the environment into the 
biochemical building blocks of life, are ubiquitous throughout the Earth’s biosphere. 
Recent years have seen a surge of interest in harnessing the power of microbial 
metabolism for large-scale production of biofuels, drugs, or other high-value chemicals. 
Fulfilling the promise of microbial cell factories requires robust, predictive models of 
metabolism, in order that the native network of a microorganism may be rewired to 
overproduce chemicals of interest by rational design [24]. To date, such models have 
fallen into two broad categories: stoichiometric constraint-based models [2] (like Flux 
Balance Analysis) and kinetic models [35]. While both approaches have been widely 
adopted by the metabolic modeling community at large, they each suffer from their own 
limitations, which we sought to partly relieve by the computational and experimental 
work presented in this dissertation.  
The first part of the dissertation is focused on inferring the metabolic goal or 
objective function of a cell from measured fluxes. Flux Balance Analysis (FBA) enables 
quantitative predictions of metabolic fluxes through a genome-scale network, based on 
the assumption that cellular metabolism has evolved to optimize a linear combination of 
reactions known as the objective function [2]. Although, in the vast majority of FBA 
publications, the objective function is made up solely of the biomass reaction, many other 
objective functions have been proposed in the literature, such that finding the most 
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suitable objective function for simulating fluxes is often non-trivial [9]. We therefore 
implemented a new algorithm called invFBA (inverse FBA) to infer the objective 
function of a cell from those intracellular fluxes that can be measured for central carbon 
metabolism with 13C-labeled substrates [1]. Identifying the correct objective function for 
a given microorganism under a given growth condition on the basis of flux data rather 
than biological hypotheses should improve the accuracy of FBA simulations and shed 
light on evolutionary trajectories. 
The second part of the dissertation focuses on novel measurements of intracellular 
enzyme flux at the single-cell level in E. coli. For over a century, the kinetics of an 
enzyme have been characterized in vitro, with, in the simplest case of an irreversible 
metabolic reaction, two Michaelis-Menten parameters: the binding affinity Km and the 
turnover rate kcat [35]. However, the dilute milieu of a test tube bears little resemblance to 
the crowded environment of a cell, which means that kinetic parameters obtained in vitro 
may not capture enzyme activity in vivo [36]. We developed a new experimental 
technique called EIFFL (Estimation of Intracellular Flux through Fluorescence Loss) for 
measuring in vivo flux through an enzyme-catalyzed reaction, as follows. An E. coli cell 
takes up and becomes saturated with a fluorescent substrate, which is later washed out of 
the culture and loses intracellular fluorescence due to in vivo enzyme activity. In addition 
to enabling studies of intracellular kinetics, EIFFL could allow rapid detection of 
antibiotic sensitivity or resistance in pathogenic E. coli strains, in cases where antibiotic 
sensitivity or resistance hinges on the expression of an enzyme [72]. 
A common thematic thread that ties together the two chapters of this dissertation 
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is variability or uncertainty in the estimation of metabolic fluxes. FBA maps out the 
space of possible flux distributions compatible with the stoichiometric model of a cell’s 
metabolism [2]. Before imposing any constraints, the cell’s distribution of metabolic 
fluxes can lie at any point in multidimensional space (the number of dimensions being 
equal to the number of reactions) [2]. After imposing stoichiometric and mass-balance 
constraints, together with upper and lower bounds on fluxes, the space of possible fluxes 
is traditionally represented as a cone [2]. Thus, while the space of possible solutions is no 
longer unbounded, it is still highly degenerate. Subsequently optimizing an objective 
function is visually depicted as singling out a point in this cone, arriving at the most 
biologically plausible flux distribution (assuming that the cell has evolved to, for 
instance, optimize growth). However, contrary to this overly simplistic visualization of 
FBA, optimization of the objective function does not converge on a single optimal 
solution [1]. In other words, there are many possible flux distributions compatible with, 
for example, optimal biomass production. This redundancy lies at the very heart of FBA, 
such that it is often impossible to determine where a cell will lie exactly within the full 
space of optimal flux distributions [1]. In the world of enzyme kinetics, it is well-known 
that cell-to-cell variability exists with regards to metabolic fluxes [87]. In the second 
chapter of this dissertation, we show that cell-to-cell variability in flux can arise even 
between cells with identical enzyme concentration. Hence, a given enzyme concentration 
does not imply a given flux through the reaction. This variability is important because it 
can give rise to clinically relevant phenotypic diversity. If activity of a given enzyme 
confers sensitivity to an antibiotic, cell-to-cell variability in the magnitude of flux 
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through the reaction could lead to the emergence of persisters, cells that outlast exposure 
to the antibiotic and successfully recolonize their habitat, leading to persistence of the 
infection.  
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CHAPTER 2:  
MAPPING THE LANDSCAPE OF METABOLIC GOALS OF A CELL 
 
The following research, published in Genome Biology in May 2016 [1], was 
carried out together with Qi Zhao, Ed Reznik, Ioannis Ch. Paschalidis, and Daniel Segrè. 
My contribution to this research was mainly the application of invFBA to simulated and 
measured flux data. 
 
Background 
 Metabolism, the chemical network that transforms nutrients supplied by the 
environment into energy and molecular building blocks, is one of the few cellular 
subsystems for which systems biology approaches can provide quantitative, testable 
predictions at a genomic scale. Flux Balance Analysis (FBA), in particular, makes it 
possible to simulate reaction fluxes through a stoichiometric constraint-based model of 
metabolism. FBA relies on the assumption that the metabolism of a cell has evolved to 
optimize an objective function, a linear combination of reactions which, in most 
implementations to be found in the literature, is simply the biomass reaction [1, 2]. 
Unlike the enzyme-catalyzed, mass-balanced reactions that make up the bulk of 
metabolic networks, the biomass reaction simulates growth by converting proteins, lipids, 
nucleic acids and other molecular building blocks into a unit of biomass in fixed 
proportions based on experimental measurements of a cell’s chemical composition.  
While maximization of the growth flux constitutes a convenient, useful and often 
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sufficiently accurate assumption for applications of stoichiometric modeling, one should 
in general consider it as the mathematical formulation of an evolutionary hypothesis 
about the criteria for natural selection in unicellular organisms. Along these lines, 
deviations and alternatives to the widespread adoption of the biomass reaction as the 
objective function have been observed and proposed. For example, throughout the years, 
a host of alternative objective functions have been shown to be biologically relevant, 
including minimization of ATP production [4], minimization of the total sum of flux 
intensities [5], and minimization of flux redistribution upon gene deletion relative to wild 
type [6]. In a recent work, metabolism in evolved strains of E. coli was shown to migrate 
away from optimal efficiency as predicted by FBA when maximizing biomass production 
[7]. Moreover, a couple of studies have targeted the possible effects of variable biomass 
composition on FBA predictions [7, 8].  
In general, identifying the objective that most accurately predicts cellular 
metabolism under a given condition can be viewed as a way to improve FBA 
calculations, as well as an avenue to advance our understanding of metabolism and its 
evolution. By dynamically regulating transcription and translation of different enzymes, 
and by allosterically fine-tuning their catalytic activities, the cell can distribute flux 
through the thousands of reactions that make up its metabolic network in a dizzying 
number of ways. The question we pose is whether it is possible to use the flux balance 
framework to associate possible metabolic objective functions to a given measured set of 
genome-scale fluxes. In other words, we seek to understand whether it is possible to say 
that a given organism was optimized to favor some reactions at the expense of others. 
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Those few attempts made to date at solving the FBA inverse problem (going from 
fluxes back to objectives) show promising results, but also a range of serious limitations, 
mainly stemming from the non-convexity of the proposed formulations which lead to 
computationally expensive solution approaches that fail to guarantee global optimality [8, 
9]. An alternative approach to estimating a true objective function [11] uses a Bayesian 
framework which relies on the assumption of normally distributed experimental fluxes 
and does not exploit the structure of the FBA problem. To fill the knowledge gap at the 
heart of FBA and dispel mere biological intuition with credible objective functions that 
reflect internal and external metabolic fluxes measured in the lab, a new, computationally 
efficient method is required. Beyond identifying a single suitable objective function, it 
should mathematically capture the space of all possible objectives compatible with a 
given set of flux measurements, even noisy ones.  
Here we develop a novel framework called invFBA (inverse FBA) to rigorously 
infer objective functions from such sets of intracellular fluxes as can be measured for 
central carbon metabolism with 13C-labeled substrates. Our invFBA formulation, based 
on linear optimization, guarantees global optimality and can be solved in polynomial 
time, unlike [9] and [10] respectively. Moreover, the output of invFBA has a meaningful 
biological interpretation. We begin by stating the mathematical formulation of invFBA 
and the regularization procedure. We next test invFBA on simulated E. coli fluxes, with 
and without noise, in order to assess its performance. After that, we validate our approach 
using time-dependent fluxes inferred from gene expression data. Finally, we apply our 
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method to fluxes measured in the central carbon metabolism of ancestral and evolved E. 
coli strains. 
 
Results 
InvFBA recovers known objective from simulated E. coli fluxes 
The objective function in FBA (Fig. 1) is encoded by a vector c, whose elements 
represent the extent to which individual fluxes tend to be maximized or minimized in the 
resource allocation problem that the cell tries to solve. Mathematically, the linear 
combination of fluxes being maximized or minimized is expressed in the form	 𝑐#𝑥#%#&' , 
where n is the total number of reactions in the model. The problem addressed by invFBA 
is to infer, from measurements of the fluxes through a cell’s metabolism under a given 
condition, the vector c that best represents its objective. Most FBA calculations include 
only one nonzero element in c, corresponding to the biomass production flux. In our 
invFBA approach, we want to assume that more complex c vectors may better capture the 
objective function implied by experimentally measured fluxes.  
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Figure 1. Schematic representation of how FBA and invFBA work. This diagram illustrates concisely 
the flow of information for invFBA calculations in this work. The right part of the figure displays 
schematic representations of the set of metabolic fluxes. Each flux vector can also be visualized on a 
metabolic chart (right-most part of the figure), where gray arrows of different thicknesses indicate 
different intensities of reaction fluxes throughout a network. The left part of the figure displays 
instead the space of metabolic objectives. Coefficients of the objective function can also be visualized 
on a metabolic chart (left-most part of the figure), with red arrows representing non-zero 
components of the objective. a) FBA uses a given objective function (here c growth) to predict a set of 
fluxes (X Opt), or multiple equivalent sets of fluxes (not shown). From one FBA solution, one can use 
invFBA to infer possible objective functions. The solution is not necessarily unique, though the space 
of possible solutions can be rigorously characterized, and contains the original objective function. b) 
InvFBA can be applied to multiple (noisy) experimental measurements of fluxes, leading, as in the 
test case of a), to a space of possible objective functions. 
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Before applying invFBA to experimental measurements of a cell’s metabolism 
whose underlying objective is unknown, we first tested invFBA on in silico fluxes 
simulated by FBA with a known objective. Using the iJO1366 metabolic model for E. 
coli [12], we simulated growth in a standard minimal medium (MOPS) under three 
different carbon source limitations: glucose, succinate, and glycerol. In all cases, the 
objective function was chosen such that FBA maximizes the biomass reaction flux. We 
next used the output flux vectors predicted by FBA (which we will refer to as the 
“observed fluxes”) as an input to invFBA. The invFBA algorithm tries to infer possible 
objective functions that could yield the observed fluxes as solutions in FBA. Our standard 
formulation of invFBA works in two steps: the first step identifies a set of objective 
functions compatible with the observed fluxes; the second step narrows down this set to a 
putative sparse objective, with a minimal L1 norm. The third step is alternatively used to 
find the sparsest objective (which has a minimal number of nonzero elements in the 
objective function) if needed. 
Upon applying invFBA to the FBA-generated observed fluxes, we found that the 
algorithm correctly recovered maximization of the biomass flux in all three conditions 
(inferred coefficients are shown in Table S7 [1]). One immediate question is whether this 
solution is unique. In order to explore the spectrum of possible equivalent invFBA 
solutions, we extended to invFBA the method of flux variability analysis often used in 
classical FBA calculations [2]. In this case, we wanted to characterize the possible range 
for each possible element in the objective function vector c. This method, which we call 
Objective Variability Analysis (OVA), determines the full range of values each 
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coefficient of the objective function can assume while being consistent with optimality. 
By running OVA to these test cases, we found that while invFBA yielded maximization 
of biomass as a solution under all conditions, alternative objective functions were equally 
compatible with the observed fluxes under the different conditions (Tables S1, S2, S3 
[1]). For instance, under succinate-limited medium, an equivalent objective function is 
the maximization of succinate uptake. While surprising at first, this result is intuitive 
considering that, to maximize growth, the cell needs to maximize uptake of its limiting 
nutrient. This simple example already points out an important aspect of FBA and its 
inverse problem, as rigorously addressed by invFBA: while the inverse algorithm rules 
out a large subset of objectives whose optimization could not possibly lead to the 
observed fluxes, different c vectors may still, when used in FBA, yield the same observed 
fluxes. Note that if two such equivalent objectives were used in the forward FBA 
problem, it is not guaranteed they will produce the same fluxes, due to the existence of 
alternative optimal solutions in FBA itself. Yet, any c inferred by invFBA will produce a 
flux distribution lying on the facet of the FBA polyhedron [25], which contains all 
optimal flux distributions. While the above analysis was focused on testing the capacity 
of invFBA to recover growth maximization as the underlying objective, one may wonder 
whether the algorithm could similarly recover alternative objectives. Towards this goal, 
we generated FBA-predicted fluxes using maximization of ATP synthase flux and 
minimization of glucose uptake for a fixed growth rate as alternative objectives. As 
shown in Tables S8 and S9 [1], the sparse invFBA algorithm consistently recovered the 
correct objective function.  
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Recovering objectives and fluxes from noisy data 
Unlike fluxes predicted by FBA simulations, experimentally observed fluxes will 
likely contain some noise that may mask the compatibility with different optimality 
criteria. For example, while any FBA flux vector predicted through the maximization of 
the biomass flux will have precisely the maximal possible growth flux value, 
experimentally measured fluxes, even if close to a growth optimum, will likely fall within 
an area around it. In order to simulate this process, and test invFBA under noisy flux 
measurements, we implemented our inverse algorithm under increasing levels of noise, 
and tested our capacity to recover the correct objective. In particular, we wanted to add 
noise to the optimal solution of FBA while keeping noisy fluxes in the feasible solution 
space (i.e., such that all reactions are in steady state and mass-balanced). This can be 
achieved by running an additional FBA-like optimization that samples random points 
close (within a given radius s2) to a previously computed FBA optimum. As shown in 
Fig. 2, as the noise approaches zero, invFBA solutions converge to having as main 
component the growth maximization objective. As the magnitude of the noise increases, 
the maximum possible value for the biomass reaction component of the objective decays 
further and further away from unity, with a major downshift at the point where the noise 
level is between 1% and 10% relative to the flux norm. At that point, the correlation is 
quickly lost, meaning that the information carried by the noisy fluxes is not informative 
of the original objective any more.  
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Figure 2. Robustness of invFBA to noise. The maximal value of the biomass coefficient cbiomass, found 
by invFBA and subsequent objective variability analysis (OVA), is plotted as a function of the level of 
noise (σ 2) in FBA-simulated flux data for E. coli. These FBA-simulated fluxes are produced using 
maximization of biomass production as the objective function. Thus, a value of cbiomass close to unity 
in OVA indicates that invFBA recovers the original objective. As the level of noise increases, 
however, our ability to recover the original objective is highly reduced. 
 
Applying invFBA to time-dependent fluxes inferred through an integrated 
expression-FBA model 
After testing the performance of invFBA on exact or noisy flux distributions 
simulated by FBA, we took a first step towards employing invFBA for the analysis of 
experimental data. In particular, we applied invFBA to genome-scale metabolic fluxes 
inferred from a combination of experimentally measured gene expression data and 
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stoichiometric modeling. In particular, Collins et al. inferred putative time-series flux 
vectors from time-series gene expression data at different stages of growth by Shewanella 
oneidensis under aerobic, carbon-limited conditions [13]. The method used for that 
analysis (temporal expression-based analysis of metabolism, TEAM [13]), extended a 
prior approach [14] by penalizing the cost of maintaining flux through a reaction with 
low gene expression. In TEAM, in contrast to prior methods, the penalty, different for 
each gene, was estimated based on a large compendium of gene expression data.  Like 
many other FBA-gene expression integration methods, TEAM does not use a biologically 
motivated pre-assumed objective function, but rather maximizes consistency with 
measured gene expression data. Thus, fluxes inferred through TEAM correspond to the 
outcome of a heuristic approach for the interpretation of expression data in terms of 
metabolic fluxes, but do not assume any prior knowledge on the metabolic objective of 
the cell. We should emphasize that, as described recently [15], integration of gene 
expression data to help predict fluxes is still problematic, partly due to the nontrivial 
relationship between mRNA and protein levels [15, 16]. However, in the context of the 
current work, the TEAM-inferred dataset gives the unique opportunity of obtaining 
putative objectives from genome-scale fluxes that reflect the metabolic effort of the 
bacterium as it undergoes changes throughout batch growth.  
As in the previous case of model-generated fluxes, the inverse problem admits a 
large space of possible solutions, i.e., maximally sparse objective functions that could 
give rise to the observed fluxes. Rather than providing specific arbitrary choices of 
objectives within the possible range, we report the outcome of OVA, as described above. 
		
15 
Among all possible components of the identified objectives, we highlight the ones that 
can be compared directly with nontrivial experimental flux measurements, e.g., pyruvate 
secretion/uptake. The scope of OVA, or, more precisely, the reactions it can include in 
the objective function, was accordingly confined to exchange reactions. As seen in Fig. 
3a, the largest pyruvate secretion component of the objective function (as computed by 
OVA) at different time points recapitulates the experimentally detected accumulation of 
pyruvate in the external medium, previously hypothesized to be the outcome of overflow 
metabolism [18]. The same trend holds for glycolate (Fig. 3b) and acetate (Fig. 3c), 
although invFBA predicts optimization of acetate secretion at several time points leading 
up to the renewed secretion of acetate at 33 h. Applied to genome-scale fluxes obtained at 
each sample along the growth curve, the integer-programming variant of invFBA 
identified biomass production as the objective function at all time points. Optimization of 
biomass production agrees with these flux distributions originating from a growing S. 
oneidensis culture [12,15]. These results lend confidence to the capacity of invFBA and 
OVA to correctly capture essential features of flux datasets. At the same time it 
highlights the importance of being cautious in the interpretation of objective functions, as 
a large component of the objective (e.g., pyruvate secretion) cannot be necessarily 
ascribed to a specifically evolved metabolic trait, and may rather be the outcome of 
undesirable overflow metabolism. 
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Figure 3. Comparison of invFBA predictions and metabolite secretions. Metabolite secretion flux 
(full line), inferred from experimental data through the TEAM approach, and maximum coefficient 
of the secretion flux in the objective function (dashed line), as predicted by invFBA (through OVA), 
are plotted as a function of time. Metabolite and gene expression data come from time-dependent 
measurements performed during batch aerobic growth of the bacterium S. oneidensis on lactate. The 
secreted metabolites are pyruvate in a), glycolate in b), and acetate in c). Positive fluxes reflect 
secretion of the metabolite in question, while negative fluxes reflect uptake. 
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Inference of objective functions in E. coli strains that underwent long-term 
evolutionary experiments 
The most interesting application of invFBA is the inference of objective functions 
for microbial species and environments for which direct flux measurements are available 
and important questions on adaptation and optimality are at stake. An excellent example 
of this scenario is the availability of recently measured metabolic flux ratios [7] for some 
of the E. coli strains that underwent long-term experimental evolution in the Lenski Lab. 
These strains were evolved for 50,000 generations in glucose minimal medium, leading 
to important observations and discoveries on how adaptation works [17, 18, 19, 20]. The 
reported flux ratios can be converted to flux vectors compatible with the stoichiometric 
constraints.  
The previous FBA analysis of metabolic activity in these strains has suggested 
that objective functions other than standard biomass flux maximization may best describe 
their evolutionary trajectory [7]. Such analysis, however, only assessed the capacity of a 
small set of specific objective functions to lead to correct fluxes. Using invFBA, it is 
possible to reanalyze these flux data in an unbiased way, and characterize the space of 
objective functions compatible with the observations. A particularly striking feature of 
the flux data was the fact that six of the strains (five evolved and the ancestral) show 
comparatively low levels of acetate secretion (or, equivalently, high levels of glucose 
oxidation), as illustrated in Fig. 4A. 
Upon applying invFBA to the complete set of measured flux data (Tables S4, S5 
[1]), we found, as in the aforementioned case studies, an infinite set of possible solutions, 
		
18 
i.e., a convex polyhedral set of objective functions. Each of these objective functions – if 
used in FBA – could give the observed fluxes as an optimal solution (one of many 
alternative optima). Interestingly, the objective function consisting of only maximization 
of growth flux is not part of any of these sets (neither for the ancestral, nor for the 
evolved). Using OVA, one can find the maximal possible contribution of the growth flux 
in the objective function (Table S6 [1]). While OVA provides ranges for the contributions 
to the objective by individual fluxes, it does not give any information on correlations and 
tradeoffs between the different flux components in the objective function. Visualization 
of the whole space of possible objective functions identified by invFBA is possible only 
upon reducing somehow the dimensionality. As illustrated in Fig. 4B, this can be 
achieved by projecting the space of possible optimal objectives onto a two-dimensional 
plane whose components are two specified biologically interesting fluxes. Upon 
visualizing this space in the plane of growth vs. respiration flux, again two sets of strains 
readily emerge, corresponding to the low- and high- respiration strains shown in Fig. 4B. 
For the same objective coefficient in the growth reaction, the low-acetate secreting strains 
have a lower maximal coefficient for respiration in the objective. The robustness of these 
results to experimental error is shown in Fig. S1 [1]. This means that, despite the freedom 
of choice of objectives compatible with the experimental data, the signatures of how 
different fluxes may have adapted is still readable from the specific boundaries of the 
space of feasible objectives. Our analysis captures the dichotomy observed at the level of 
acetate and glucose transport fluxes, and suggests that the low acetate-excretion strains 
may be interpreted as having a higher maximization of respiration. 
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Figure 4. Application of invFBA to long-term evolved E. coli strains. a) Experimental measurements 
(by Harcombe et al. [7]) of acetate excretion and glucose uptake for the ancestral (red star) and 
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evolved (blue and red dots) E. coli strains from Lenski’s long-term evolutionary experiment. The red 
and blue colors are used here to highlight two distinct metabolic regimes that different strains seem 
to cluster around. b) A projection (onto a two-dimensional subspace) of the set of objective functions 
compatible with experimentally measured fluxes. The graph is obtained through a two-dimensional 
version of OVA: for each possible value of the growth flux coefficient of the objective function 
(cBiomass), one can find the minimal and maximal value of the objective function coefficient for the 
respiratory flux (cRespiration), obtaining areas that correspond to objective functions compatible with 
the measured fluxes. Such regions can be computed for the ancestral and all evolved E. coli strains. 
The strains corresponding to the different metabolic regimes (blue and red dots in a) map onto 
different regions in the space of objectives, labeled with similar colors. 
 
Discussion 
To identify the most fitting objective function for a given set of observed fluxes, 
we formulated invFBA as an optimization problem whose linearity guarantees global 
optimality and polynomial computation. In general, there exist no unique solution to the 
invFBA optimization. For example, to optimize growth, the cell must simultaneously 
optimize other reactions, like uptake of the limiting nutrient. Even with additional 
heuristics (such as sparsity or regularization), it may be impossible to identify a single 
appropriate objective; instead a whole set of objectives can be equally compatible with 
the data. It is important to note that this is a fundamental theoretical limit associated with 
linear optimization-based metabolic network models in general, rather than a limit in 
algorithmic capabilities. One possible interesting application of this uncertainty might be 
in the field of metabolic engineering, where it is often difficult to specifically evolve a 
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desired trait. One could envisage that, using a variant of our invFBA framework, it would 
be possible to search for pairs of objectives such as maximization of one would likely 
also yield optimization of the other. While the large space of possible objectives 
compatible with almost any flux distribution is intrinsic to the complex nature of 
metabolic networks, it presents a challenge to the biological insight potentially gleaned 
from invFBA. Inducing sparsity through integer programming readily collapses the space 
of optimality into a few objective functions with clear biological meaning, as shown in 
our TEAM analysis (Fig. 4). Alternatively, generating flux distributions in FBA with 
objectives sampled from the large space of optimality outlined by invFBA, then 
comparing these computed fluxes with observed fluxes might enable us to associate with 
each objective a certain probability and subsequently select the most likely objective (not 
unlike the work in [11]). Furthermore, flux coupling analysis [24], an established method 
in the literature, could serve as a means to group together closely related metabolic 
reactions, thereby reducing the dimensionality of the objective space captured by 
invFBA. Within the boundaries of the fundamental uncertainty quantifiable with OVA, 
invFBA succeeds in recovering the true underlying objective function from simulated 
fluxes, among less biologically meaningful, albeit equally optimal objectives. With 
simulated data, the true solution was known a priori, since the “observed fluxes” were 
calculated in FBA by optimizing biomass production.  The addition of different degrees 
of noise allowed us to estimate the level of experimental error in the measurements 
beyond which information about the underlying objective function is unrecoverable. The 
real relevance of invFBA is however in the capacity to receive as input actual 
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experimental data, inherently noisy, and pertaining to biological systems for which the 
true solution (i.e., the objective being optimized) is unknown.  Future inverse problems 
would benefit from analysis under different conditions, in order to find objectives that are 
common to the different conditions.  
Our inverse algorithm can be particularly useful for analyzing evolutionary 
experiments, where the objective functions can be thought of as a high-level 
representation of targets of selection, which can be inferred based on flux measurements. 
Here, we exemplified this concept by applying our approach to measured fluxes from the 
E. coli “Lenski lines” [17, 18, 19, 20]. While all strains evolved faster rates of glucose 
uptake, which largely accounts for their greater growth rates, six strains further optimized 
respiratory efficiency, consistent with measurements of lower acetate secretion 
(alternatively, higher efficiency of glucose oxidation). The well-known trade-off between 
metabolic rate and yield allows fermentative yeast to outcompete other single-cellular 
organisms by rapidly exhausting a carbon source. One might speculate that low-
respiration Lenski strains, much like yeast, favor a high-rate strategy at the expense of 
yield, whereas high-respiration strains favor a high-yield strategy at the expense of rate. 
However, Fig. 4A shows rates of glucose uptake to be comparable between both sets of 
evolved E. coli populations, with means of 14.8 and 15.3 mmol/grDW*h for high- and 
low-respiration strains respectively. Low yields of glucose utilization do not, therefore, 
confer high rates of glucose uptake to evolved populations of E. coli. One way to 
interpret our results is to consider that evolving faster means of glucose uptake most 
likely overwhelms enzymes responsible for glucose breakdown and energy conservation. 
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As a result, in strain REL1, for instance, the rate of acetate secretion amounts to almost 
half the rate of glucose consumption. Evidently, while all E. coli populations evolved 
faster glucose uptake, only half were also able to adapt their catabolic enzymes to 
efficiently utilize additional glucose. As seen in Fig. 4A, only high-respiration 
populations could bring down their ratio of acetate production to glucose uptake to levels 
seen in the ancestral strain. Thus, invFBA gives readily interpretable results for 
experimental fluxes, without the benefit of prior knowledge concerning the true 
underlying objective of the cell.  
Interpreting a set of fluxes belonging to a metabolic model with hundreds of 
reactions is a sophisticated mathematical task, and our present formulation of invFBA 
lays much-needed groundwork for future efforts in trying to infer cell-level goals from 
flux measurements. While efficient and overall capable of providing biological insight, 
invFBA still carries some of the limitations inherent in the definition of a linear metabolic 
objective function. In particular, as argued before [25], the weighted sums of reaction 
fluxes, inferred as putative objective functions, are not necessarily easily interpretable in 
terms of biological processes. This is in contrast to the classical LP example from 
economics, in which weights often represent the costs of different products of processes 
and the optimization seeks to minimize a linear combination that amounts to total 
expenses. By virtue of a common unit of currency, the weighted sum (or cost function) 
adds up to a number, in dollars, with intuitive meaning. The weighted sum becomes 
difficult to interpret quantitatively in the context of metabolic models, since different 
reactions do not necessarily use the same “currency”. Interestingly, however, the 
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weighted sum can be mapped onto the space of Pareto optimality, whose interpretation is 
well-understood [3, 22], tracing the boundary between two competing objectives where 
one can increase only at the expense of the other. Notably, as pointed out in [25], 
weighted sums capture the Pareto frontier only when said frontier is convex, which may 
not be in general the case within metabolic models. 
An additional factor to take into consideration when interpreting the weights 
computed by invFBA for different fluxes contributing to the objective function is the 
possibility of biases and inaccuracies merely due to the wide range of magnitudes of 
different fluxes in a model. The growth reaction, for example, typically assumes values 
on the order of 1 hr-1, while the glucose uptake is often about 20 mmol/(gDW*hr). An 
objective function built as a linear combination of these two fluxes with equal weights 
would tend to skew the results towards maximizing glucose uptake, just due to the higher 
numerical reward of the ensuing solution. One would have to heavily weight the growth 
flux to see any flux through this reaction, resulting conversely in a skewed distribution of 
weights. The specific values of the weights should therefore not be necessarily 
considered as reflecting the importance of the respective fluxes in the objective. The 
typical numerical magnitude of the involved fluxes should be taken into account when 
attempting biological interpretations of the objective function coefficients. For example, 
in our study of evolved E. coli strains from the Lenski Lab, two fully coupled reactions 
belonging to the same linear metabolic pathway, identified in the small E. coli model [27] 
by flux coupling analysis [24], only give degenerate solutions in the space of possible 
objective functions provided they share the same numerical flux value (e.g. transketolase 
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and transaldolase in the pentose phosphate pathway, Fig. S2 [1]). In interpreting invFBA 
results one should also keep in mind that wide differences in the characteristic values of 
different fluxes may favor specific solutions. These problems are similar to issues 
commonly raised and discussed in other flux balance modeling methods, such as the 
weights of different fluxes in MOMA [6], parsimonious FBA [28], and crowding-
dependent FBA [29]. Reformulating the problem with normalized variables could 
alleviate this issue, but at the expense of increased problem complexity and nonlinearity. 
For example, normalizing objective coefficients by the number of carbon atoms at play in 
any given reaction might allow a fair comparison across all weights calculated through 
invFBA. 
A last important caveat about the current formulation of invFBA is that it requires 
a complete flux distribution as input. Given that 13C-labeled nutrient experiments can 
usually only quantify fluxes for a small number of reactions in central carbon 
metabolism, invFBA from experimental flux measurements would only be possible for 
reduced stoichiometric models, like the one used in our analysis of the “Lenski lines” 
[30]. For this type of experimental data, future versions of invFBA could infer objectives 
directly from the measured flux ratios, thereby minimizing the chance of propagation of 
errors across multiple algorithms.  
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Methods 
Flux balance analysis (FBA) 
To mathematically formulate FBA, let S denote the stoichiometric matrix of 
dimensions m x n where m is the number of metabolites and n the number of metabolic 
fluxes, x the vector of metabolic fluxes (internal and external), c the vector of coefficients 
expressing the cellular objective (e.g. biomass), Zopt the optimal objective value, and xlb, 
xub lower and upper bounds, respectively, on the metabolic fluxes, implied by empirical 
evidence of irreversibility or by nutrient availability in growth medium [2]. The FBA 
problem is formulated as: 
 
(1.1) 
where 0 is the vector of all zeroes and primes indicate transpose. 
 
Inverse flux balance analysis (invFBA) 
Let us assume we have a set of N measured metabolic flux vectors xi, where i = 1, 
…, N. Let us also assume that, due to measurement noise, these flux vectors are not 
necessarily optimal for a specific objective, even if they are feasible solutions of the FBA 
problem (Equation 1.1). With x* denoting an optimal solution of Equation 1.1, let ϵi ≥ 0 
denote the suboptimality gap of xi, i.e. the distance between the measured objective 
function value and the predicted one. This implies: 
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(1.2) 
The invFBA problem consists of finding a set of objective functions that 
minimize this suboptimality gap. Through duality theory, the problem can be formulated 
as the following linear programming problem: 
 
(1.3) 
where the second, third, and fourth constraint in the display above define the feasible 
space of objective functions compatible with the measured fluxes (a cone C), defined in 
terms of the dual variables p, q1, q2 (associated with the FBA problem in Equation 1.1), 
the first constraints introduces a normalization which guarantees a non-zero solution, and 
ZIopt denotes the minimal total suboptimality gap of the measured metabolic flux 
distributions xi. 
We propose Equation 1.4 as a subsequent step in invFBA to minimize the L1-
norm of optimal c = (c1, …, cn) vectors obtained from solving the problem in 
Equation 1.3: 
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(1.4) 
Part of the optimal solution of the problem in Equation 1.4 is a sparse c vector 
that renders the given set of measured metabolic flux distributions x1, …, xN near-optimal 
in the FBA optimization (Equation 1.1). One can then interpret non-zero elements of c as 
corresponding to important metabolic fluxes that are critical in the FBA optimization 
context and provide a minimal description of the cellular objective function. In the 
sequel, when we refer to an invFBA algorithm, we mean the two-step procedure of 
solving the problems in Equations 1.3 and 1.4. Alternative regularization schemes are 
illustrated in the Additional file 1: Supplementary Methods and Additional file 13: Figure 
S3 [1], and a formal proof of a theorem establishing that solutions c of invFBA guarantee 
each measured xi to be near-optimal for the FBA (Equation 1.1) can be found in [31]. 
Problem [9] is a linear programming problem minimizing the L1 norm of the vector c. It 
can be viewed as a convex relaxation of a problem with identical constraints, which 
minimizes the L0 norm of c (i.e. the number of non-zero elements in c). The latter 
problem can be formulated as an integer programming problem.  
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An important observation is that both problems in Equations 1.3 and 1.4 that 
comprise our invFBA algorithm are linear programming problems. This is important 
because it guarantees a global optimal solution (as opposed to earlier approaches as in [9] 
resulting in non-convex problems). Moreover, very efficient polynomial-time algorithms 
exist for solving such problems. It is interesting that the complexity of the invFBA 
algorithm matches that of FBA — both are linear programing problems, which, in 
general, is not true for inverse optimization problems [10, 11]. We note that the duality 
approach to inverse optimization has been used in a more general setting in [32]; 
however, to the best of our knowledge, ours is the first attempt to rigorously characterize 
the set of FBA objective functions consistent with a potentially noisy set of 
measurements. 
 
Inference of fluxes from experimentally measured branching ratios 
 To apply the invFBA algorithm and infer the objective function in E. coli strains 
that underwent long-term evolutionary experiments (LTEE), we needed to convert the 
13C-labeling raw measurements of flux ratios and uptake/secretion rates into central 
carbon metabolism flux values. The dataset we used is obtained from [30]. This dataset 
includes measurements for one ancestral strain (Anc) and ten evolved strains (named, as 
in the original paper, A+1, A+2, A+3, A+4, A+5, A–1, A–2, A–4, A–5, A–6). For each 
strain, six pathway branch ratios (Ser from glycolysis, PYR though ED pathway, upper 
bound of PEP through PPP, lower bound of PYR from MAL, OAA from PEP, PEP from 
OAA) and three external fluxes (glucose uptake rate, acetate excretion rate and growth 
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rate) are available. All fluxes are part of a central carbon metabolism model for E. coli 
with stoichiometric matrix S. In our formulation, we call 𝑅iS (s = 1, …, 11; i = 1, …, 6) 
the measured pathway branch ratio i of strain s and 𝐸iS (s = 1, ..., 11; j =1, 2, 3) the 
measured value of external flux j of strain s. Each flux ratio 𝑅iS can be expressed in terms 
of the flux vectors, appropriately weighted by two vectors 𝒂𝒊 ∈ 𝑅𝒏 and 𝒃𝒊 ∈ 𝑅𝒏: 
 
(1.5) 
These equations can be reformulated as standard linear equations:  
 
(1.6) 
where the ith row of A is 𝒂𝒊 – 𝒃𝒊 𝑅iS, i = 1,…, 6. Translating the measured ratios and 
external fluxes to a feasible flux distribution for strain s is posed as the following 
optimization problem (Equation 1.4): 
 
(1.7) 
where 𝛽 is a coefficient determining the feasible range (here, we set 𝛽 = 1), and 𝑠𝑡𝑑jS is 
the standard deviation of the measurements of external flux j of strain s. The problem in 
Equation 1.4 is a standard quadratic programming problem yielding the flux distribution, 
which is the closest one to the measured pathway branch ratio and is consistent with the 
stoichiometry constraints and external flux measurements. The problem can be solved 
efficiently and global optimality can be guaranteed. The optimal solution 𝐱S of Equation 
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1.4 is the feasible flux distribution for strain s and can be used to test our invFBA 
algorithm.
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CHAPTER 3:  
IMAGING METABOLIC FLUX IN SINGLE E. COLI CELLS 
 
Introduction 
Both for metabolic engineering applications and pure biological discovery, a 
major trend in recent years has been to transition cell biology from a descriptive, 
qualitative field to a rigorous, quantitative one, which lends itself to predictive modeling 
and takes into account the noise inherent in any biological system [16, 33, 34]. So far, 
such efforts have largely focused on quantifying both steps in the central dogma of 
biology, from DNA to mRNA [34] and from mRNA to protein [16]. How proteins in turn 
shape cell phenotype has received much less attention, including metabolic enzymes that 
convert nutrients into the building blocks of life. Since the introduction of the Michaelis-
Menten equation in the early 20th century [35], the activity of a purified enzyme (as 
captured, in the simplest possible case of a monomolecular irreversible reaction, by two 
kinetic parameters, namely the binding affinity Km and the turnover rate kcat) has been 
described in vitro. A major limitation of this classical approach lies in the stark 
differences between the dilute milieu of a test tube and the crowded environment of a 
cell, where macromolecules make up about 20% of the total mass [36–38]. It is therefore 
a commonplace of publications on enzyme kinetics to caution that parameters obtained in 
vitro may have little relevance to in vivo conditions [39, 40]. Characterizing enzyme 
activity in vivo [40, 41] would yield insight into not only the scale of metabolic fluxes, 
but, by extension, how the cell might optimally allocate resources to enzyme production 
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to bring about the desired phenotype.  
Monitoring flux through a reaction in vivo has potential applications beyond 
furthering our quantitative understanding of bacterial metabolism. The spread of 
microorganisms with resistance to multiple antibiotics poses a growing threat to global 
public health [42]. Blind and indiscriminate use of antibiotics promotes the rise of 
multidrug resistant strains, and endangers patients in cases where the prescribed 
antibiotics fail [42]. The Minimum Inhibitory Concentration (MIC), or the lowest 
concentration of an antibiotic to inhibit growth of a microorganism, is traditionally 
measured by culturing bacteria alongside a gradient of antibiotic concentrations [43]. 
Since such antimicrobial susceptibility testing can be time-consuming (requiring at least 
24 hours), antibiotics are normally prescribed to patients without prior knowledge of their 
effectiveness against the pathogen at issue [43]. Point-of-care diagnostics to evaluate 
antimicrobial susceptibility before initiating a regime of antibiotics would at once guide 
medical treatment and slow the emergence of multidrug resistance [43]. Existing 
approaches for point-of-care detection of antibiotic resistance range, in nature, from 
genomic [44–46], nanomechanical [47], microfluidic [48, 49], mass spectrometric [50], 
morphological [51], colorimetric [52], to fluorescent [53–58]. The last approach focuses 
on antibiotic analogs that gain fluorescence upon being metabolized by a resistance-
conferring enzyme like beta-lactamase [53–58]. In fact, there already exist multiple such 
fluorogenic substrates for measuring nitroreductase activity in bacteria [59–64]. 
However, to date, this broad method of inferring antibiotic resistance has relied on the 
gradual accumulation of the fluorescent molecule in the bulk medium.  
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The noisy process of translation is most commonly investigated using a 
fluorescent protein like YFP [16] because quantifying the abundance of all native 
proteins at the single-cell level presents ostensibly insurmountable challenges. Similarly, 
while enzymes exhibit an endless variety of shapes, mechanisms, substrates, and products 
[65], measuring the flux through each one in vivo and at the single-cell level is 
technically impracticable. Instead, it would be both pragmatic and illuminating to study 
one enzyme/substrate pair that offers the convenience of fluorescence, and infer lessons 
that might apply to all enzymes in the cell. While there exist multiple fluorogenic probes 
for specific enzymes (like fluorescein diacetate for esterases [92] or coumberone for aldo-
keto reductases [93]), these are non-fluorescent substrates that become fluorescent upon 
undergoing an enzymatic reaction. Without knowledge of the intracellular substrate 
concentration, studying the kinetics of a metabolic reaction is infeasible. Here we 
introduce a novel method named EIFFL (Estimation of Intracellular Flux through 
Fluorescence Loss) for measuring the flux through an enzyme-catalyzed reaction in vivo 
using a fluorescent substrate. As shown in Fig. 5A, the cell takes up the fluorescent 
substrate that is subsequently washed out of the medium, whereupon the activity of the 
enzyme on the intracellular substrate is tracked over time. For EIFFL to work, a number 
of basic criteria have to be met: (1) the substrate must lose fluorescence upon undergoing 
an enzyme-catalyzed reaction, (2) this reaction must be very far from equilibrium, i.e. 
effectively irreversible (since the product is non-fluorescent and its intracellular 
concentration cannot be estimated), (3) the rate of substrate uptake must exceed the rate 
of the reaction (so the substrate can accumulate inside the cell), (4) the substrate must be 
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taken up irreversibly (so it does not leak out of the cell after being removed from the 
medium), and, optionally, (5) the enzyme can be tagged with a fluorescent domain 
(whose spectra differ from the substrate to distinguish them) without compromising its 
activity. If every condition is satisfied, the abundance of substrate, the abundance of 
enzyme, and the rate of the reaction can each be measured directly inside a single cell. 
EIFFL thus has the advantage over past efforts that intracellular fluxes can be isolated 
and do not have to be deconvolved from uptake kinetics of the substrate and release 
kinetics of the product [66].  
	 	
Figure 5. A) General Schematic of EIFFL. Fluorescent molecule A is taken up from the medium and, 
in the process, converted to A*, which cannot diffuse out of the cell. Once the cell becomes saturated 
with A, the latter is washed out of the medium. Fluorescent substrate A* is metabolized by enzyme E 
into non-fluorescent product B, in accordance with irreversible Michaelis-Menten kinetics. B) 
Schematic of EIFFL with 2-NBDG as Substrate and NfsA as Enzyme. 2-NBDG is phosphorylated at 
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the 6’ position as it enters E. coli, which prevents it from later leaking out of the cell. After washing 
away extracellular 2-NBDG, reduction of intracellular 2-NBDG by nfsA with NADPH is measured 
via loss of fluorescence. 
A substrate/enzyme pair that would permit EIFFL was successfully identified in 
2-NBDG/nfsA. The substrate 2-NBDG [67] is comprised of a D-glucose molecule 
tethered at the 2’ position to a nitroaromatic NBD moiety that fluoresces much like GFP 
(Fig. 6A). While it is primarily used today for real-time monitoring of glucose uptake in 
mammalian cells [67], 2-NBDG was originally developed in E. coli [68], where it was 
found to be metabolized to a non-fluorescent derivative by an unidentified enzyme [69]. 
We speculated that a nitroreductase (a protein that reduces nitro groups [63]) might be the 
unidentified enzyme based on two separate clues. First, since loss of 2-NBDG 
fluorescence has been shown to slow down in the presence of the metabolic inhibitor 2,4-
dinitrophenol, reducing equivalents like NADH or NADPH that depend on an active 
metabolism were proposed to play a role [70]. Second, reducing NBD’s nitro group with 
dithionite is known to convert it to a non-fluorescent amine [71]. E. coli has one major 
nitroreductase called nfsA (NitroFuran Sensitivity A) that confers strong sensitivity to 
nitrofurantoin [72], an important antibiotic for the treatment of Urinary Tract Infections 
(UTIs) since the 1950s [73]. Upon being reduced by nfsA using NADPH, its nitro group 
becomes the highly reactive amidogen and damages multiple targets within the cell, 
including ribosomal proteins, DNA, and carbohydrate metabolism [73]. Even when 
tagged with a YFP domain, we have found nfsA to likewise reduce the nitro group 
associated with the NBD moiety of 2-NBDG, causing irreversible loss of fluorescence 
(Fig. 5B and Fig. 6A). Moreover, E. coli carries active, energy-consuming glucose 
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transporters that hydrolyze ATP such that 2-NBDG is phosphorylated at the C-6 position 
as it is taken up, effectively trapping it inside the cell [74]. The rapid and irreversible 
nature of 2-NBDG uptake in E. coli is crucial in enabling EIFFL. Our technique 
introduces a new paradigm for swiftly detecting enzyme activity directly inside single 
cells. In the case of 2-NBDG, EIFFL could allow rapid identification of nitrofurantoin 
sensitivity in pathogenic E. coli, where resistance has been found to hinge on deleterious 
mutations to the nfsA gene [75] (Fig. 6B). 
 
Figure 6. Chemical Description of the Reduction of 2-NBDG (A) and Nitrofurantoin (B) by NfsA. 2-
NBDG is a fluorescent nitroaromatic D-glucose derivative whose excitation and emission spectra 
resemble GFP’s. However, 2-NBDG loses fluorescence when its nitro group undergoes reduction by 
the nitroreductase nfsA using NADPH. Nitrofurantoin is an antibiotic commonly prescribed to treat 
UTIs, whose nitro group is reduced by nfsA into the highly reactive amidogen, which is toxic to E. 
coli. 
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Figure 7. General Protocol of EIFFL. 
 
Methods 
Strains and Plasmids 
Wild-type E. coli strains BW25113 and MG1655, together with mutant E. coli 
strains lacking the nfsA or nfsB gene (referred to as E. coli ΔnfsA or ΔnfsB respectively, 
both from the Keio collection [76]) were obtained from the E. coli Genetic Stock Center 
at Yale. A double-knockout strain E. coli ΔnfsAB was engineered by first removing the 
antibiotic resistance marker from E. coli ΔnfsA with plasmid pCP20 [77] and then 
transferring the ΔnfsB mutation by P1 phage transduction [78]. The ΔnfsA mutation was 
transferred by the same mechanism to E. coli strains BL21AI and BL21(DE3), which 
were used to express the nfsA-YFP fusion protein and overexpress the nfsA enzyme 
respectively. After PCR-amplifying the nfsA gene from the extracted DNA of E. coli 
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MG1655, it was incorporated into the Gateway [79] entry vector pDONR221 and 
subsequently moved into the T7-mediated overexpression plasmid pDEST17, which 
includes a poly-histidine tag for downstream purification of the enzyme. The Venus 
variant of YFP was likewise PCR-amplified from the genome of strain SX1685 [16] and 
fused to the C-terminus of nfsA by overlap extension PCR [80]. Again using the Gateway 
cloning technology [79], the nfsA-YFP fusion protein was incorporated into pDONR221 
and subsequently moved into the destination vector pDEST14. 
 
Media and Chemicals 
5 mg of 2-NBDG (Thermo Fisher, Catalog # N13195) were resuspended in 500 
µL 200 proof ethanol (Sigma). 10 µL of the 2-NBDG solution were aliquoted into 1-mL 
Eppendorf microcentrifuge tubes. These were placed in a refrigerated SpeedVac (Savant, 
SVC 100H) for 20 minutes to evaporate the ethanol, followed by storage in a -20°C 
freezer. An aliquot’s 2-NBDG was resuspended in 10 µL MilliQ H2O before each 
experiment. M9 minimal medium contained 5× Difco™ M9 Minimal Salts (BD), 2 mM 
MgSO4 (Fisher), and 0.1 mM CaCl2 (Sigma) in MilliQ H2O, autoclaved. To provide a 
carbon source, the M9 minimal medium was supplemented with either 0.04% D-glucose 
(VWR) or 10 mM sodium pyruvate (Fisher). LB Broth Miller (5 g/L yeast extract, 10 g/L 
peptone from casein, and 10 g/L sodium chloride) was obtained from EMD Millipore. If 
the E. coli strain contained a pDEST plasmid, carbenicillin (Sigma) was added to the 
medium to a final concentration of 100 µg/mL. A fresh 50 mg/mL stock solution of 
nitrofurantoin (98%, ACROS Organics) was prepared in DMSO (Fisher) before each 
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experiment. The buffer for assaying in vitro enzyme kinetics was 50 mM Tris-HCl 
(Fisher) at pH 7, and a fresh 25 mg/mL NADPH stock solution was prepared in MilliQ 
H2O from NADPH tetrasodium salt hydrate (96%, ACROS) before each experiment. A 
10% L-arabinose stock solution (ACROS) served as inducer of nfsA-YFP. 
 
Measuring Loss of 2-NBDG Fluorescence due to NfsA Activity 
A starter culture (2 mL Luria broth in a test tube) was grown overnight from a 
single colony in an incubator shaker (37°C, 200 rpm). 10 mL of M9 minimal medium 
(0.04% glucose) in a conical flask were inoculated with 10 µL of starter culture and 
grown in an incubator shaker (37°C, 200 rpm) for 18 hours, at which point it reached a 
stationary-phase OD600 of ~0.35. To achieve a wide gradient of nfsA-YFP concentrations 
across a single population, 4 such cultures were prepared that also received 0.01%, 
0.001%, 0.0001%, or 0% L-arabinose. At the end of the 18-h growth period, these 4 
cultures were combined in equal proportions.   
The general protocol for EIFFL is shown in Fig. 7. A 1-mL culture sample was 
given 1 µL of a 30 mM 2-NBDG stock solution (30 µM final 2-NBDG concentration) 
and vortexed before being placed in a 40°C water bath for 10 minutes. The sample was 
centrifuged at 6,000x g for 1 min and resuspended in M9 (pre-incubated at 37°C) with no 
carbon source. Loss of 2-NBDG fluorescence was then immediately measured in a plate 
reader, flow cytometer, or microscope. In the first case, 2-NBDG fluorescence was 
measured every 5 minutes in a BioTek Gen5 plate reader with excitation and emission 
filters set respectively to 460/40 and 528/20. Alternatively, the fluorescence distribution 
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across 1,000 cells was measured in a BD FACScalibur flow cytometer with samples 
removed every 10 minutes from a 37°C water bath. The controls in Fig. 8AB refer to E. 
coli cells that were never exposed to 2-NBDG. Single E. coli cells expressing nfsA-YFP 
were imaged on 1.5% agarose pads (M9 with no carbon source) at 100x every 3 minutes 
using a Nikon Eclipse Ti-E microscope, with the temperature of the chamber set to 37°C. 
While 2-NBDG is typically associated with GFP filter sets [67], substituting the CFP HQ 
filter cube was found to severely limit bleed-through from nfsa-YFP fluorescence while 
appropriately capturing 2-NBDG fluorescence. At the end of the 40-minute time-lapse, 
once 2-NBDG fluorescence had all but disappeared, nfsA-YFP fluorescence was 
conventionally measured with the YFP HQ filter cube. Images were analyzed in 
MATLAB using the SuperSegger software [81], resulting in 430 correctly segmented 
cells. Since loss of 2-NBDG fluorescence was found to be exponential, an equation of the 
form F(t) = Ae–λt was fit to cell fluorescence over time, yielding a decay rate λ for each 
cell.  
 
Purification and In Vitro Characterization of NfsA 
BL21(DE3) ΔnfsA / pDEST17 (nfsA) was grown in 100 mL LB (with 100 µg/mL 
ampicillin) in an incubator shaker (37°C, 200 rpm) until the OD600 reached 0.4. 
Overexpression of nfsA was induced for 3 hours with 0.4 mM IPTG. Cells were then 
washed with PBS and resuspended in 1 mL of 50 mM Tris-HCl (pH 7). The cell 
suspension was sonicated on ice with a Branson Digital Sonifier at 20 % amplitude (10 
bursts of 10 seconds at 30 second intervals). Cell debris was spun down at 15,000x g for 
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15 minutes (4°C) and the lysate filter-sterilized (0.2 µm pore size). The nfsA enzyme was 
purified using the HisPur™ Ni-NTA Spin Purification Kit (Thermo Fisher, Catalog # 
88227), before being spun down through a Pierce protein concentrator (Thermo Fisher, 
Catalog # 88502) and dialyzed against 50 mM Tris-HCl (pH 7) with a Slide-A-Lyzer™ 
Dialysis Cassette (Thermo Fisher, Catalog # 66005). The purity of the eluted protein was 
confirmed by SDS-PAGE. 
10 µL of pure nfsA and 1 µL of a 25 mg/mL NADPH solution were added to 90 
µL of 50 mM Tris-HCl (pH 7). The mixture was incubated at 37°C for 5 min to allow 
binding of nfsA to NADPH. The control was identical but for the omission of nfsA. The 
reaction was initiated by adding 1 µL of a 30 mM 2-NBDG solution. Simultaneous 
reduction of 2-NBDG and oxidation of NADPH were followed in a BioTek Gen5 plate 
reader. 2-NBDG fluorescence was measured as before, while NADPH oxidation was 
tracked via 340 nm absorbance (unlike NADP+, NADPH has a strong peak at said 
wavelength [82]). 
 
Correlating 2-NBDG Reduction and the Antibiotic Efficacy of Nitrofurantoin 
20 mL of LB were inoculated with a single colony of E. coli MG1655 and grown 
in an incubator shaker (37°C, 200 rpm) for 72 h (Fig. 11). The culture was washed twice 
in M9 and diluted to an OD600 of 0.1. The same 2-NBDG assay as described above was 
performed in a plate reader, only with and without 10 mM sodium pyruvate in the final 
medium where 2-NBDG undergoes intracellular reduction. Nitrofurantoin was then 
added to the diluted culture to a concentration of 50 µg/mL. This parent culture was split 
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into two subcultures of equal volume (10 mL), one of which received 10 mM sodium 
pyruvate. The two subcultures were replaced in the incubator shaker for another 24 h, at 
the end of which period, the number of CFUs per mL of each subculture was quantified 
by plating. 
 
Results and Discussion 
In both flow cytometer (Fig. 8AB) and plate reader (Fig. 9), intracellular 
reduction of 2-NBDG by nfsA returns cell fluorescence to control levels within an hour, 
following an exponential decay. While the ΔnfsA mutant shows some decline, it still 
fluoresces strongly even after 4 hours of incubation, in keeping with our hypothesis that 
nfsA is the key mediator of 2-NBDG reduction. Another nitroreductase in E. coli, nfsB, 
does not appear to reduce 2-NBDG, based on comparing the single-knockout ΔnfsB with 
WT and the double-knockout ΔnfsAB with ΔnfsA (Fig. 9). Still, the measurable decrease 
in fluorescence of ΔnfsA and ΔnfsAB points to other unidentified nitroreductases in E. 
coli. In order to rule out the possibility that deletion of nfsA might only be indirectly 
responsible for loss of 2-NBDG fluorescence by, for example, adversely affecting 
NADPH regeneration, we purified the nfsA enzyme and showed that 2-NBDG reduction 
by nfsA could occur in vitro. As expected, 2-NBDG fluorescence decreases sharply in the 
presence of nfsA (Fig. 10A), simultaneously with the oxidation of NADPH to NADP+ 
reflected by measurements of 340 nm absorbance [82] (Fig. 10B). However, it should be 
underscored that the above enzyme assay was performed with unphosphorylated 2-
NBDG as substrate, in contrast to the phosphorylated 2-NBDG that nfsA would 
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encounter inside an E. coli cell [74]. Future work should confirm that nfsA is indeed 
active on the phosphorylated derivative of 2-NBDG.  
 
Figure 8. Fluorescence Distribution at Different Stages of Intracellular 2-NBDG Reduction in Wild-
Type (A) and ΔnfsA (B) E. coli. Fluorescence intensities were measured across 1,000 cells in a flow 
cytometer 0, 10, 20, 30, 40, 50, and 60 minutes after incubation with 2-NBDG and resuspension in M9 
medium.  
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Figure 9. Time-Series Measurements (Plate Reader) of Cell Fluorescence in Wild-Type, ΔnfsA, 
ΔnfsB, and ΔnfsAB E. coli after Incubation with 2-NBDG and Resuspension in M9 Medium. 
 
Figure 10. Pure NfsA Oxidizes NADPH to Reduce 2-NBDG, Causing a Decrease in Fluorescence by 
2-NBDG (A) and 340-nm Absorbance by NADPH (B).  
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Point-of-care detection of antibiotic sensitivity from clinical samples would 
greatly slow down the emergence of multidrug resistance. A bacterial concentration in 
urine of at least 102 – 103 CFU/mL [83] is taken to be indicative of a UTI. Such a low cell 
concentration (corresponding to an OD600 of 10-7 – 10-6) demands an exquisitely sensitive 
assay to detect antibiotic resistance without relying on colony growth. As proven by flow 
cytometry (Fig. 8AB), EIFFL is not dependent on bulk fluorescence measurements of a 
turbid culture but can successfully discriminate between WT and ΔnfsA at the single-cell 
level. Since clinical isolates of resistant E. coli have been shown to lack a functional nfsA 
gene [75], EIFFL can thus infer nitrofurantoin sensitivity within minutes. The simplicity 
of the EIFFL protocol places it well within the means of any microbiology lab. 
We next tested whether antibiotic sensitivity to nitrofurantoin correlates with the 
rate of 2-NBDG reduction. Without a carbon source, late-stationary phase E. coli could 
not fully reduce 2-NBDG to zero fluorescence, likely due to a scarcity of NADPH (Fig. 
12A). Conversely, adding 10 mM pyruvate caused the collapse of 2-NBDG fluorescence, 
as breakdown of the carbon source propagated through metabolism and regenerated 
NADPH (Fig. 12A). Without nitrofurantoin, adding pyruvate to the minimal medium led 
to robust cell growth (OD600 0.463±0.016 from an initial OD600 of 0.1), while leaving out 
a carbon source logically did not (OD600 0.104±0.005 from an initial OD600 of 0.1). 
However, after a 24-hour incubation period with nitrofurantoin, the opposite pattern is 
observed: the number of CFUs per mL is lower with pyruvate than without (Fig. 12B). 
This reversal is consistent with our knowledge that nitrofurantoin depends on NADPH 
pools for its antibiotic efficacy [84] no less than 2-NBDG depends on them for loss of 
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fluorescence. The growing prevalence of multidrug resistance has caused a renewed 
interest in better leveraging existing antibiotics, either by combinatorial use [85] or 
potentiation [86]. EIFFL can suggest possible strategies to enhance the effectiveness of 
an antibiotic like nitrofurantoin by stimulating the metabolism of E. coli. 
 
Figure 11. Protocol for Testing Positive Correlation between 2-NBDG Reduction and Nitrofurantoin 
Antibiotic Efficacy. E. coli MG1655 was grown in LB for 72 h, whereupon its ability to reduce 2-
NBDG was measured with and without 10 mM sodium pyruvate. Nitrofurantoin was added to the 
parent culture, which was then split into two subcultures of equal volume. One of the two subcultures 
received 10 mM sodium pyruvate, and both were grown for another 24 h. Finally, the number of 
CFUs/mL of each subculture was assessed by plating. 
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Figure 12. Pyruvate Causes Both Faster 2-NBDG Reduction (A) and Greater Antibiotic Killing by 
Nitrofurantoin (B).  
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In order to correlate flux with enzyme concentration, we engineered an nfsA-YFP 
fusion protein to estimate its intracellular abundance at the single-cell level. Overall, E. 
coli cells expressing more nfsA-YFP reduced 2-NBDG perceptibly faster than those 
expressing less (Fig. 14AB). Still, this positive correlation between enzyme abundance 
and flux is a noisy one, with a Pearson coefficient of 0.55. While some theoretical work 
has been carried out on the subject [87, 88], flux noise is still a burgeoning concept in cell 
biology, and multiple hypotheses can be put forward for why it is observed here. While 
2-NBDG is uniformly distributed across the cell (Fig. 13A), nfsA-YFP tends to cluster at 
a pole, seemingly forming inclusion bodies (Fig. 13B). One possible explanation for this 
clustering pattern is that nfsA localizes to the periphery of the cell. However, a recently 
synthesized nfsA-RFP fusion protein was uniformly distributed across each E. coli cell 
(data not shown), rendering it more likely that clustering is due to the YFP domain and 
not nfsA. Such clustering has been noticed before in cases where fluorescent proteins 
dimerize [89], as YFP does [90]. Part of the observed flux noise may be an artifact of 
how we quantify nfsA-YFP, normalizing it across the area of the cell despite its tendency 
to clump. Alternatively, it may be due to differential expression of other unidentified 
nitroreductases in E. coli suggested by Fig. 9, which should be identified and deleted in 
future work. The contribution of unidentified nitroreductases to 2-NBDG reduction is 
negligible in stationary phase (Fig. 9), but becomes less so in exponential phase or when 
a carbon source is provided (data not shown). Also, nfsA presumably has native 
substrates in the cell that compete with 2-NBDG for access to the enzyme’s binding sites. 
Dramatically greater concentrations of native substrates in one cell over another would 
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exclude 2-NBDG and reduce the observable flux through the reaction, even if the two 
cells shared identical levels of nfsA-YFP. Although the high uptake rate of glucose 
derivatives makes it probable that 2-NBDG overwhelms the still-unknown native 
substrates of nfsA, this assumption is unproven in our work. The most biologically 
interesting explanation for noisy fluxes is that stationary-phase E. coli cells are highly 
heterogeneous in metabolic states and, by extension, their NADPH pools. A limitation of 
the current work is that NADPH is not quantified in single E. coli cells alongside 2-
NBDG and nfsA-YFP. Future efforts should identify a simple one-substrate/one-enzyme 
system where all actors can be distinguished. 
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Figure 13. 100x Microscopy Images of E. coli Cells Pre-Incubated with 2-NBDG (A) and Expressing 
NfsA-YFP (B). 
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Figure 14. A) Loss of 2-NBDG Fluorescence over Time in 430 E. coli Cells Expressing NfsA-YFP. 
Relative concentration of nfsA-YFP in each cell is indicated by the color of the plot, which ranges 
		
53 
from black (no YFP fluorescence) to yellow (high YFP fluorescence). B) Correlating Flux with the 
Concentration of NfsA-YFP Enzyme. The decay rate λ (inferred by fitting each plot in Fig. 14A to an 
exponential of the form F(t) = Ae–λt) serves as a measure of flux through the reaction. 
Finally, EIFFL will enable us to probe enzyme kinetics at the single-cell level by 
affording measurements of all variables in the irreversible Michaelis-Menten equation: 
(1) the concentration of enzyme (nfsA-YFP fluorescence), (2) the concentration of 
substrate (2-NBDG fluorescence), and (3) the flux through the reaction (2-NBDG's 
exponential decay in fluorescence). We plan to assess the biological relevance of in vitro 
kinetic parameters compiled in databases like BRENDA [91] by comparing the enzyme 
kinetics of nfsA-YFP in a test tube to those inside a crowded cell [36]. We also hope 
organic chemists will be motivated to identify or synthesize other fluorescent analog 
substrates susceptible to EIFFL and with strong biological or clinical relevance. 
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CHAPTER 4:  
CONCLUSION 
 
Stoichiometric constraint-based modeling and kinetic modeling are the two 
dominant theoretical frameworks in use today for simulating microbial metabolism. In 
many ways, they are mirror images of one another. FBA requires relatively few 
parameters (mainly, the uptake rate of the limiting nutrient), whereas kinetic models 
contain many (a kcat and KM for possibly hundreds of enzymes). The mathematical 
formulation of FBA is simple, being reducible to a stoichiometric matrix codifying all the 
metabolic reactions in the cell, together with upper and lower bounds on each flux. 
Conversely, kinetic models are mathematically complex, comprised of a long list of 
differential equations without any closed-form solution. As a result, FBA is 
computationally tractable, with a single execution of linear programming being complete 
in a fraction of a second, while kinetic modeling is computationally taxing, with 
differential equations that demand to be solved numerically, in time-consuming, stepwise 
fashion. On the other hand, the space of possible solutions (i.e. the space of possible flux 
distributions across the metabolic network) is large in FBA and small in kinetic modeling 
(assuming a given set of kinetic parameters and initial conditions). Kinetic models also 
have the advantage that they are time-dependent, whereas FBA only considers a steady-
state solution. Finally, while metabolite concentrations (and, by extension, substrate-level 
regulation) are accounted for in kinetic modeling, they do not exist in FBA. 
Two novel techniques, computational and experimental in nature, for refining 
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these modeling approaches were presented above. In the case of stoichiometric modeling, 
we developed an algorithm called invFBA to infer the metabolic goal or objective 
function of the cell from experimentally measured fluxes. In the end, we wish to arrive at 
more sophisticated objective functions, substantiated by available data, than the simplistic 
assumption, widely adopted across the FBA community, of maximal biomass production. 
We believe the best way to arrive at these more nuanced objective functions, customized 
to a given microorganism growing in a given environment, is to apply invFBA on many 
different datasets. Even though most 13C-labeled nutrient experiments are tailored only to 
central carbon metabolism (which represents a small subset of reactions in a genome-
scale model), a wealth of such flux data is steadily accumulating in the literature, 
providing fertile ground for invFBA to identify those specific reactions which, when 
coupled with biomass production in an objective function, appropriately capture 
measured flux distributions. In part to improve the accuracy of kinetic models, we 
developed an experimental technique called EIFFL that enables characterization of 
intracellular fluxes in single E. coli cells. In the future, it will be interesting to repeat 
these experiments substituting nfsA-YFP with nfsA-RFP, which does not form inclusion 
bodies and yields an unambiguous measure of enzyme concentration per cell. Moreover, 
much like nfsA-YFP, nfsA-RFP retains all of the nitroreductase activity on 2-NBDG of 
the native nfsA enzyme. Ultimately, we hope EIFFL will be extended to a systematic 
comparison of in vivo and in vitro enzyme kinetics, which will in turn lend greater 
credibility to the field of kinetic modeling.  
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Chapter 1 (Introduction) of this dissertation included mention of variability or 
uncertainty in the estimation of metabolic fluxes as a common thread of both projects. 
FBA, for example, cannot yield a single flux distribution from a single objective function. 
Instead, a whole space of flux distributions is consistent with optimization of the 
objective function. Chapter 2 further showed that, not only is the space of optimal flux 
distributions redundant when implementing FBA, many equally optimal objective 
functions arise when implementing invFBA. In other words, running invFBA on a set of 
measured metabolic fluxes does not yield a single optimal objective function. On a 
related note, due to the structure of metabolic models, where pathway branches lead to 
the biosynthesis of multiple essential metabolites, it may be impossible to optimize 
production of one molecule through metabolic engineering without simultaneously 
optimizing production of other closely related ones. Chapter 3 showed that, while 2-
NBDG reduction is positively correlated with nfsA-YFP concentration at the single-cell 
level, a given enzyme concentration does not necessarily imply a given flux through the 
reaction. Rather, a whole range of flux magnitudes can be consistent with one specific 
intracellular concentration of nfsA-YFP. Several alternative explanations can be put 
forward for this pattern, including variable NADPH pools across the population in 
stationary-phase E. coli. Indeed, boosting NADPH regeneration in late-stationary phase 
E. coli through consumption of pyruvate was shown to cause faster 2-NBDG reduction, 
in addition to potentiating nitrofurantoin. While we correlated 2-NBDG reduction and 
nitrofurantoin efficacy at the population level, it will be interesting to also do so at the 
single-cell level with nfsA-RFP, to test whether a given enzyme concentration not only 
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fails to imply a given rate of 2-NBDG reduction, but, by extension, a given probability of 
cell death from exposure to nitrofurantoin. 
Even when metabolic modeling finally comes to full fruition in its predictive 
power, metabolism itself will still constitute only a piece of cellular systems biology. 
Equally important is a quantitative understanding of the regulatory networks that control 
gene expression and of the purely mechanistic aspects of the cell, such as maintaining 
membrane integrity, swimming towards nutrients via chemotaxis, and proper cell 
division. Only when all of these disparate aspects of a physical cell are rationally 
integrated with metabolism will we arrive at a reliable whole-cell model of E. coli, which 
we can control and rewire for our own purposes. 
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